Results 121 to 130 of about 10,461 (217)

Lessons learned from a SIRT2-selective inhibitor

open access: yesOncotarget, 2016
Developing targeted cancer therapies typically starts with the identification of oncoproteins that are mutated or over-activated in tumors, followed by the development of small molecules that target the oncoproteins. A paradigm example is the development of Gleevec targeting the BCR-ABL oncoprotein in chronic myeloid leukemia.
Jing, Hui, Lin, Hening
openaire   +2 more sources

SIRT2 Inhibition Rescues Neurodegenerative Pathology but Increases Systemic Inflammation in a Transgenic Mouse Model of Alzheimer’s Disease [PDF]

open access: yes
Sirtuin 2 (SIRT2) has been proposed to have a central role on aging, inflammation, cancer and neurodegenerative diseases; however, its specific function remains controversial.
Aleixo, M.   +17 more
core   +1 more source

Suppression of Hepatocellular Carcinoma by Deletion of SIRT2 in Hepatocytes via Elevated C/EBPβ/GADD45γSummary

open access: yesCellular and Molecular Gastroenterology and Hepatology
Background & Aims: There is a gap in our understanding of mechanisms promoting hepatocellular carcinoma (HCC), and this limits our ability to provide targeted therapy interventions for HCC.
Fang Wang   +10 more
doaj   +1 more source

Protective Effects of SIRT2 Inhibition on Cardiac Fibrosis

open access: yesThe Anatolian Journal of Cardiology
A primary factor in the pathogenesis of aging is oxidative stress, with cardiac inflammation and fibrosis being contributed to by increased oxidative stress as organisms age. Oxidative stress enhances the cardiac fibrotic signaling pathway, with reactive oxygen species inducing cardiac fibrosis through increased expression of the profibrotic factor ...
Akbulut, Muge   +6 more
openaire   +3 more sources

SIRT2 counteracts primate cardiac aging

open access: yesNature Aging, 2023
Laura Cox, Michael Olivier
openaire   +2 more sources

Stabilization of P/CAF, as a ubiquitin ligase toward MDM2, suppresses mitotic cell death through p53-p21 activation in HCT116 cells with SIRT2 suppression [PDF]

open access: yes
We previously reported that the suppression of SIRT2, an NAD + -dependent protein deacetylases, induces p53 accumulation via degradation of p300 and the subsequent MDM2 degradation, eventually leading to apoptosis in HeLa cells.
80305573   +13 more
core  

The anti-proliferative effect of a bergamot juice extract and its flavanones in leukemic THP-1 cell line involves SIRT2

open access: yesAtti della Accademia Peloritana dei Pericolanti - Classe di Scienze Medico-Biologiche
Plant kingdom provides a wide plethora of remedies which can be exploited to treat prevent and manage human ailments, among which cancer. In these regards, there is consistent supporting evidence of the beneficial properties of Citrus fruits, which are ...
Alessandro Maugeri   +3 more
doaj   +1 more source

NMN partially rescues cuproptosis by upregulating sirt2 to increase intracellular NADPH

open access: yesScientific Reports
Cuproptosis is characterized by lipoylated protein aggregation and loss of iron–sulfur (Fe–S) proteins, which are crucial for a wide range of important cellular functions, including DNA replication and damage repair. Sirt2 and sirt4 are lipoamidases that
Yingying Zhang   +9 more
doaj   +1 more source

Computational Design and Optimization of Peptide Inhibitors for SIRT2

open access: yesPharmaceuticals
Sirtuin 2 (SIRT2), an NAD+-dependent deacetylase, is crucial for regulating vital physiological processes, including aging, DNA repair, and cell cycle progression. Its abnormal activity is linked to diseases such as Parkinson’s disease, cancer, and metabolic disorders, making it a potential target for therapeutic intervention.
Heba A. Alkhatabi   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy